- Home
- GSHD vs XENE Comparison
GSHD vs XENE Comparison
Compare GSHD & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSHD
- XENE
- Stock Information
- Founded
- GSHD 2003
- XENE 1996
- Country
- GSHD United States
- XENE Canada
- Employees
- GSHD N/A
- XENE N/A
- Industry
- GSHD Specialty Insurers
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- GSHD Finance
- XENE Health Care
- Exchange
- GSHD Nasdaq
- XENE Nasdaq
- Market Cap
- GSHD 2.7B
- XENE 2.5B
- IPO Year
- GSHD 2018
- XENE 2014
- Fundamental
- Price
- GSHD $108.37
- XENE $29.75
- Analyst Decision
- GSHD Buy
- XENE Strong Buy
- Analyst Count
- GSHD 10
- XENE 11
- Target Price
- GSHD $115.40
- XENE $54.82
- AVG Volume (30 Days)
- GSHD 296.7K
- XENE 1.3M
- Earning Date
- GSHD 04-23-2025
- XENE 05-12-2025
- Dividend Yield
- GSHD 5.45%
- XENE N/A
- EPS Growth
- GSHD 129.07
- XENE N/A
- EPS
- GSHD 1.26
- XENE N/A
- Revenue
- GSHD $324,757,000.00
- XENE $7,500,000.00
- Revenue This Year
- GSHD $18.40
- XENE N/A
- Revenue Next Year
- GSHD $24.82
- XENE $611.23
- P/E Ratio
- GSHD $86.19
- XENE N/A
- Revenue Growth
- GSHD 21.87
- XENE N/A
- 52 Week Low
- GSHD $54.80
- XENE $26.74
- 52 Week High
- GSHD $130.39
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- GSHD 51.48
- XENE 35.37
- Support Level
- GSHD $104.53
- XENE $29.21
- Resistance Level
- GSHD $114.76
- XENE $31.74
- Average True Range (ATR)
- GSHD 3.56
- XENE 1.56
- MACD
- GSHD 0.76
- XENE -0.46
- Stochastic Oscillator
- GSHD 54.98
- XENE 13.39
About GSHD Goosehead Insurance Inc.
Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.